0001752724-23-283056.txt : 20231218 0001752724-23-283056.hdr.sgml : 20231218 20231218160228 ACCESSION NUMBER: 0001752724-23-283056 CONFORMED SUBMISSION TYPE: N-CEN/A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20230430 FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 EFFECTIVENESS DATE: 20231218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXCHANGE TRADED CONCEPTS TRUST CENTRAL INDEX KEY: 0001452937 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: N-CEN/A SEC ACT: 1940 Act SEC FILE NUMBER: 811-22263 FILM NUMBER: 231493674 BUSINESS ADDRESS: STREET 1: 10900 HEFNER POINTE DRIVE STREET 2: SUITE 400 CITY: OKLAHOMA CITY STATE: OK ZIP: 73120 BUSINESS PHONE: 405-778-8377 MAIL ADDRESS: STREET 1: 10900 HEFNER POINTE DRIVE STREET 2: SUITE 400 CITY: OKLAHOMA CITY STATE: OK ZIP: 73120 FORMER COMPANY: FORMER CONFORMED NAME: FAITHSHARES TRUST DATE OF NAME CHANGE: 20090717 FORMER COMPANY: FORMER CONFORMED NAME: FAITHSHARES INC DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: VERITAS FUNDS INC DATE OF NAME CHANGE: 20081230 0001452937 S000042659 ROBO Global(R) Robotics and Automation Index ETF C000131868 ROBO Global(R) Robotics and Automation Index ETF ROBO 0001452937 S000065729 ROBO Global(R) Artificial Intelligence ETF C000212574 ROBO Global(R) Artificial Intelligence ETF THNQ 0001452937 S000065730 ROBO Global(R) Healthcare Technology and Innovation ETF C000212575 ROBO Global(R) Healthcare Technology and Innovation ETF HTEC 0001452937 S000068816 Nifty India Financials ETF C000219897 Nifty India Financials ETF INDF 0001452937 S000076793 KPOP and Korean Entertainment ETF C000236828 KPOP and Korean Entertainment ETF KPOP N-CEN/A 1 primary_doc.xml X0404 N-CEN/A 0001752724-23-152095 LIVE 0001452937 XXXXXXXX 811-22263 N-1A S000065729 true S000065730 true S000042659 true S000076793 true S000068816 true EXCHANGE TRADED CONCEPTS TRUST 811-22263 0001452937 549300TXJW88BSB0KL90 10900 HEFNER POINTE DRIVE SUITE 400 OKLAHOMA CITY 73120 US-OK US 4057788377 SEI INVESTMENTS DISTRIBUTION CO. 1 Freedom Valley Drive OAKS 19456 610-676-1000 Records as Distributor for Trust Vident Investment Advisory, LLC 300 Colonial Center Parkway Suite 330 Roswell 30076 1-404-487-1961 Records as sub-advisor for Trust Exchange Traded Concepts, LLC 10900 Hefner Pointe Drive SUITE 400 Oklahoma City 73120 1-405-778-8377 Records as Advisor for Trust SEI INVESTMENTS GLOBAL FUNDS SERVICES 1 Freedom Valley Drive OAKS 19456 610-676-1000 Records as Administrator for Trust Bank of New York Mellon 240 Greenwich Street New York 10286 1-212-495-1784 Records as Custodian and Transfer Agent for Trust BROWN BROTHERS HARRIMAN & CO. 40 Water Street Boston 02109 617-772-1818 Records as Custodian and Transfer Agent for Trust N N N N-1A 20 Y Mark Zurack N/A N Timothy Jacoby N/A N Stuart Strauss N/A N J. Garrett Stevens N/A Y Linda Petrone N/A N Matthew B. Fleischer N/A 295 Madison Avenue 26th Floor New York 10017 XXXXXX N N N N N SEI INVESTMENTS DISTRIBTUION CO. 8-27897 000010690 N/A N N Cohen & Company, Ltd 925 N/A N N N N N N N ROBO Global(R) Artificial Intelligence ETF S000065729 549300AO11OCTHSACQ26 N 1 0 0 Exchange-Traded Fund N N 0.36 -0.31 0.594677425 0.586921522 Y N Y N Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N/A 0.00000000 0.00000000 Rule 6c-11 (17 CFR 270.6c-11) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N Exchange Traded Concepts LLC 801-70485 000151197 549300BB5DRIKK8VVV91 N The Bank of New York Mellon 085-05006 HPFHU0OQ28E4N0NFVK49 N N N IHS Markit 549300HLPTRASHS0E726 GB N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N S&P 549300U4VWNITEKO2881 N Bloomberg 254900BF4G8VMW8GG471 N Pricing Direct 549300WIC0TOJ7N7GD54 N Thomson Reuters Corporation 549300561UZND4C7B569 CA N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N SEI Investments Global Funds Services 801-24593 SEC File Number N N N SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 BTIG LLC 008-65473 000122225 549300GTG9PL6WO3EC51 6795.06000000 GOLDMAN, SACHS & CO. 008-00129 000000361 FOR8UP27PHTHYVLBNG30 5.24999999 PERSHING LLC 008-17574 000007560 ZI8Q1A8EI8LQFJNM0D94 147.76000000 MISCHLER FINANCIAL 8-48067 000037818 2549004IPXPSM9EJFC92 321.43999999 7269.51000000 0.00000000 N 24467918.78999999 N N N ROBO Global(R) Healthcare Technology and Innovation ETF S000065730 549300DWX5221AQZYJ12 N 1 0 0 Exchange-Traded Fund N N 0.02 -0.65 0.256710343 0.227797487 Y N Y N Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N/A 0.00000000 0.00000000 Rule 32a-4 (17 CFR 270.32a-4) Rule 6c-11 (17 CFR 270.6c-11) Y Y N N Exchange Traded Concepts, LLC 801-70485 000151197 549300BB5DRIKK8VVV91 N Bank of New York Mellon 085-05006 HPFHU0OQ28E4N0NFVK49 N N N Pricing Direct 549300WIC0TOJ7N7GD54 N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Bloomberg 254900BF4G8VMW8GG471 N S&P 549300U4VWNITEKO2881 N IHS Markit 549300HLPTRASHS0E726 GB N Thomson Reuters Corporation 549300561UZND4C7B569 CA N N Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N SEI Investments Global Funds Services 801-24593 SEC File Number N N N SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 BTIG LLC 008-65473 000122225 549300GTG9PL6WO3EC51 17700.25 MISCHLER FINANCIAL 8-48067 000037818 2549004IPXPSM9EJFC92 22498.45 40198.70 0.00000000 N 108467999.40 N N N ROBO Global(R) Robotics and Automation Index ETF S000042659 549300DWX5221AQZYJ12 N 1 0 0 Exchange-Traded Fund N N 0.17 -0.83 0.213233752 0.177509456 Y N Y N N Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Administrative fee 58344139.70 748509.85 Rule 6c-11 (17 CFR 270.6c-11) Rule 32a-4 (17 CFR 270.32a-4) N N N N Exchange Traded Concepts, LLC 801-70485 000151197 549300BB5DRIKK8VVV91 N Vident Investment Advisory, LLC 801-80534 000171004 254900XSZB691Z1A6X78 2023-02-10 Bank of New York Mellon 085-05006 HPFHU0OQ28E4N0NFVK49 N N N Thomson Reuters Corporation 549300561UZND4C7B569 CA N IHS Markit 549300HLPTRASHS0E726 GB N Pricing Direct 549300WIC0TOJ7N7GD54 N S&P 549300U4VWNITEKO2881 N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Bloomberg 254900BF4G8VMW8GG471 N N HONGKONG AND SHANGHAI BANKING CORPORATION, HONG KONG N/A HK N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON SA/NV N/A NL N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A FR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A GB N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) SKANDINAVISKA ENSKILDA BANKEN, STOCKHOLM N/A SE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) SKANDINAVISKA ENSKILDA BANKEN, HELSINKI BRANCH N/A FI N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A NL N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CREDIT SUISSE (SWITZERLAND) LTD (T2S) N/A CH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A DE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CIBC MELLON TRUST COMPANY N/A CA N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HSBC SHANGHAI-HONG KONG STOCK CONNECT SPSA N/A HK N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HSBC BANK (TAIWAN) LIMITED N/A TW N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) MUFG BANK, LTD N/A JP N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) SKANDINAVISKA ENSKILDA BANKEN AB, OSLO BRANCH N/A NO N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON SA/NV, ASSET SERVICING, NIEDERLASSUNG FRANKFURT AM MAIN N/A DE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) BANK HAPOALIM B.M. N/A IL N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) DEUTSCHE BANK-SEOUL BRANCH N/A KR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A FI N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) ESES FRANCE REGISTERED N/A FR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) EUROCLEAR BANK, BRUSSELS N/A BE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) ESES FRANCE BEARER N/A FR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CREDIT SUISSE (SWITZERLAND) LTD N/A CH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N SEI Investments Global Funds Services 801-24593 SEC File Number N N N SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 RBC CAPITAL 008-45411 000031194 549300LCO2FLSSVFFR64 3124.62 PERSHING LLC 008-17574 000007560 ZI8Q1A8EI8LQFJNM0D94 16119.73 JP MORGAN 008-35008 000000079 ZBUT11V806EZRVTWT807 47781.84 IMPERIAL CAPITAL 008-50397 000043744 549300I8X15KSI64Y307 19822.44 RBC DAIN RAUSCHER INC. 008-45411 000031194 549300LCO2FLSSVFFR64 5813.83 VIRTU FINANCIAL BD LLC 8-60815 000148390 54930088MP91YZQJT494 21969.49 UBS SECURITIES LLC 008-22651 000007654 T6FIZBDPKLYJKFCRVK44 25434.15 BTIG LLC 008-65473 000122225 549300GTG9PL6WO3EC51 50031.33 BLAIR, WILLIAM, & COMPANY, L.L.C. 008-02698 000001252 549300J0P7XYE8BMZ775 4881.69 MISCHLER FINANCIAL 8-48067 000037818 2549004IPXPSM9EJFC92 116483.59 311834.92 0.00 N 1251872894.99 N N N KPOP and Korean Entertainment ETF S000076793 549300XJ30PASCLTXR72 Y 1 0 0 Exchange-Traded Fund N N 1.6 0.88 3.22244893 3.172322975 N N N N N/A 0.00000000 0.00000000 Rule 32a-4 (17 CFR 270.32a-4) Rule 6c-11 (17 CFR 270.6c-11) N N N N Exchange Traded Concepts, LLC 801-70485 000151197 549300BB5DRIKK8VVV91 N The Bank of New York Mellon 085-05006 HPFHU0OQ28E4N0NFVK49 N N N Thomson Reuters Corporation 549300561UZND4C7B569 CA N Pricing Direct 549300WIC0TOJ7N7GD54 N Bloomberg 254900BF4G8VMW8GG471 N S&P 549300U4VWNITEKO2881 N IHS Markit 549300HLPTRASHS0E726 GB N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N SEI INVESTMENTS GLOBAL FUNDS SERVICES 801-24593 N N N MISCHLER FINANCIAL 8-48067 000037818 2549004IPXPSM9EJFC92 4679.30999999 4679.30999999 0.00000000 N 2470742.75999999 N N N Nifty India Financials ETF S000068816 5493002SQJ8SYE3VG403 N 1 0 0 Exchange-Traded Fund N N -1.59 -2.37 1.768823641 1.739144743 Y N N N N/A 0.00000000 0.00000000 Rule 6c-11 (17 CFR 270.6c-11) Rule 32a-4 (17 CFR 270.32a-4) N N N N Exchange Traded Concepts, LLC 801-70485 000151197 549300BB5DRIKK8VVV91 N BROWN BROTHERS HARRIMAN & CO. 084-60256 5493006KMX1VFTPYPW14 N N N S&P 549300U4VWNITEKO2881 N Thomson Reuters Corporation 549300561UZND4C7B569 CA N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Pricing Direct 549300WIC0TOJ7N7GD54 N Bloomberg 254900BF4G8VMW8GG471 N IHS Markit 549300HLPTRASHS0E726 GB N N BROWN BROTHERS HARRIMAN & CO. 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N BROWN BROTHERS HARRIMAN & CO. 5493006KMX1VFTPYPW14 N N N SEI Investments Global Funds Services 801-24593 SEC File Number N N N SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 MISCHLER FINANCIAL 8-48067 000037818 2549004IPXPSM9EJFC92 171.20999999 BTIG LLC 008-65473 000122225 549300GTG9PL6WO3EC51 2508.58999999 2679.79999999 0.00000000 N 7870192.84999999 N N N KPOP and Korean Entertainment ETF S000076793 N 10000.00 100.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 700.00000000 0.00000000 0.00000000 700.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N Nifty India Financials ETF S000068816 N 25000.00 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N ROBO Global(R) Artificial Intelligence ETF S000065729 Y 25000.00 6.41593843 0.17394298 93.58406156 0.17394298 5.59090997 0.34417552 94.40909002 0.34417552 0.00000000 550.00000000 0.00000000 0.00000000 550.00000000 0.00000000 0.00000000 550.00000000 0.00000000 0.00000000 550.00000000 0.00000000 Y ROBO Global(R) Robotics and Automation Index ETF S000042659 Y 25000.00 14.27609594 1.74750229 85.72390405 1.74750229 9.69702480 2.66122556 90.30297519 2.66122556 0.00000000 941.17647058 0.00000000 0.00000000 941.17647058 0.00000000 0.00000000 974.35897435 0.00000000 0.00000000 974.35897435 0.00000000 N ROBO Global(R) Healthcare Technology and Innovation ETF S000065730 Y 25000.00 2.50377627 0.90531531 97.49622372 0.90531531 1.07750874 0.26383873 98.92249125 0.26383873 0.00000000 412.50000000 0.00000000 0.00000000 550.00000000 0.00000000 0.00000000 515.62500000 0.00000000 0.00000000 0.00000000 0.00000000 Y false false true false false false INTERNAL CONTROL RPT 2 INDF_ICL.txt INTERNAL CONTROL LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders of Nifty India Financials ETF and Board of Trustees of Exchange Traded Concepts Trust In planning and performing our audit of the financial statements of Nifty India Financials ETF (the "Fund"), a series of Exchange Traded Concepts Trust, as of and for the year ended April 30, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A fund's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) providereasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the designor operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be materialweaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of April 30, 2023. This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. COHEN & COMPANY, LTD. Cleveland, Ohio June 23, 2023 INTERNAL CONTROL RPT 3 KPOP_ICL.txt INTERNAL CONTROL LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders of KPOP and Korean Entertainment ETF and Board of Trustees of Exchange Traded Concepts Trust In planning and performing our audit of the financial statements of KPOP and Korean Entertainment ETF (the "Fund"), a series of Exchange Traded Concepts Trust, as of and for the period from September 1, 2022 (commencement of operations) through April 30, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N- CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A fund's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) providereasonable assurance that transactions are recorded as necessary to permitpreparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the designor operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, suchthat there is a reasonable possibility that a material misstatement of the Fund's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of April 30, 2023. This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. COHEN & COMPANY, LTD. Cleveland, Ohio June 23, 2023 INTERNAL CONTROL RPT 4 ROBO_ICL.txt INTERNAL CONTROL LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders of ROBO Global Healthcare Technology and Innovation ETF, ROBO Global Robotics and Automation Index ETF, and ROBO Global Artificial Intelligence ETF and Board of Trustees of Exchange Traded Concepts Trust In planning and performing our audit of the financial statements of ROBO Global Healthcare Technology and Innovation ETF, ROBO Global Robotics and Automation Index ETF, and ROBO Global Artificial Intelligence ETF (the "Funds"), each a series of Exchange Traded Concepts Trust, as of and for the year ended April 30, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds' internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds' internal control over financial reporting. Accordingly, we express no such opinion. The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A fund's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) providereasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund's assets that could havea material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the designor operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, suchthat there is a reasonable possibility that a material misstatement of the Funds' annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds' internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be materialweaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds' internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of April 30, 2023. This report is intended solely for the information and use of management and the Board of Trustees of the Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. COHEN & COMPANY, LTD. Cleveland, Ohio June 23, 2023